ArticleCureus2025
Stroke-Like Symptoms Status-Post Tenecteplase (TNK) Administration: A Rare Case of Hemiplegic Migraine.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemiplegic migraine (HM) is an uncommon type of migraine, often misdiagnosed as an ischemic stroke due to its similar clinical presentation. We present a case of a 39-year-old female, with a past medical history of migraine headaches, who presented to the emergency department with sudden onset left-sided facial droop and left lower extremity deficits for two hours. A CT scan of the head was negative for any acute intracranial hemorrhage. The National Institutes of Health Stroke Scale (NIHSS) score was 5, and tenecteplase (TNK) was subsequently administered. Further work-up revealed unremarkable MRI of the brain with and without contrast, sinus rhythm serial EKGs without evidence of any arrhythmias, and unremarkable troponins. The transthoracic echocardiogram (TTE) was unremarkable for any intracardiac shunts. The patient's symptoms were ultimately attributed to HM, given that the work-up for all other etiologies was ruled out. It is crucial for clinicians to perform thorough histories and physical exams for prompt detection and management of HMs and to minimize exposure to the potential adverse effects of thrombolytic agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.